Evidence map›Paper›PMID 39061606›Full record

ArticleDiagnostics (Basel, Switzerland)2024

A Qualitative Evaluation of ChatGPT4 and PaLM2's Response to Patient's Questions Regarding Age-Related Macular Degeneration.

George Adrian Muntean, Anca Marginean, Adrian Groza, Ioana Damian, Sara Alexia Roman, Mădălina Claudia Hapca, Anca Mădălina Sere, Roxana Mihaela Mănoiu, Maximilian Vlad Muntean, Simona Delia Nicoară

Abstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

George Adrian MunteanDepartment of Ophthalmology, "Iuliu Hatieganu" University of Medicine and Pharmacy, Emergency County Hospital, 400347 Cluj-Napoca, Romania.ORCID 0000-0003-1567-254X
Anca MargineanDepartment of Computer Science, Technical University of Cluj-Napoca, 400114 Cluj-Napoca, Romania.ORCID 0000-0001-8426-588X
Adrian GrozaDepartment of Computer Science, Technical University of Cluj-Napoca, 400114 Cluj-Napoca, Romania.ORCID 0000-0003-0143-5631
Ioana DamianDepartment of Ophthalmology, "Iuliu Hatieganu" University of Medicine and Pharmacy, Emergency County Hospital, 400347 Cluj-Napoca, Romania.ORCID 0000-0003-4301-7112
Sara Alexia RomanFaculty of Medicine, "Iuliu Hatieganu" University of Medicine and Pharmacy, 400347 Cluj-Napoca, Romania.ORCID 0009-0002-5856-1487
Mădălina Claudia HapcaDepartment of Ophthalmology, "Iuliu Hatieganu" University of Medicine and Pharmacy, Emergency County Hospital, 400347 Cluj-Napoca, Romania.ORCID 0000-0002-8391-9754
Anca Mădălina SereDepartment of Ophthalmology, "Iuliu Hatieganu" University of Medicine and Pharmacy, Emergency County Hospital, 400347 Cluj-Napoca, Romania.ORCID 0009-0005-7020-8493
Roxana Mihaela MănoiuAugenzentrum Gelsenkircen, 45894 Gelsenkirchen, Germany.ORCID 0009-0001-7989-7476
Maximilian Vlad MunteanDepartment of Plastic Surgery, "Prof. Dr. I. Chiricuta" Institute of Oncology, 400015 Cluj-Napoca, Romania.ORCID 0000-0003-0709-8779
Simona Delia NicoarăDepartment of Ophthalmology, "Iuliu Hatieganu" University of Medicine and Pharmacy, Emergency County Hospital, 400347 Cluj-Napoca, Romania.ORCID 0000-0002-7886-2044

Funding

Executive Agency for Higher Education, Research, Development and Innovation Funding (UEFISCDI) PN-III-P2-2.1-PED-2021-2709
6 · The paper itself

Abstract

Patient compliance in chronic illnesses is essential for disease management. This also applies to age-related macular degeneration (AMD), a chronic acquired retinal degeneration that needs constant monitoring and patient cooperation. Therefore, patients with AMD can benefit by being properly informed about their disease, regardless of the condition's stage. Information is essential in keeping them compliant with lifestyle changes, regular monitoring, and treatment. Large language models have shown potential in numerous fields, including medicine, with remarkable use cases. In this paper, we wanted to assess the capacity of two large language models (LLMs), ChatGPT4 and PaLM2, to offer advice to questions frequently asked by patients with AMD. After searching on AMD-patient-dedicated websites for frequently asked questions, we curated and selected a number of 143 questions. The questions were then transformed into scenarios that were answered by ChatGPT4, PaLM2, and three ophthalmologists. Afterwards, the answers provided by the two LLMs to a set of 133 questions were evaluated by two ophthalmologists, who graded each answer on a five-point Likert scale. The models were evaluated based on six qualitative criteria: (C1) reflects clinical and scientific consensus, (C2) likelihood of possible harm, (C3) evidence of correct reasoning, (C4) evidence of correct comprehension, (C5) evidence of correct retrieval, and (C6) missing content. Out of 133 questions, ChatGPT4 received a score of five from both reviewers to 118 questions (88.72%) for C1, to 130 (97.74%) for C2, to 131 (98.50%) for C3, to 133 (100%) for C4, to 132 (99.25%) for C5, and to 122 (91.73%) for C6, while PaLM2 to 81 questions (60.90%) for C1, to 114 (85.71%) for C2, to 115 (86.47%) for C3, to 124 (93.23%) for C4, to 113 (84.97%) for C5, and to 93 (69.92%) for C6. Despite the overall high performance, there were answers that are incomplete or inaccurate, and the paper explores the type of errors produced by these LLMs. Our study reveals that ChatGPT4 and PaLM2 are valuable instruments for patient information and education; however, since there are still some limitations to these models, for proper information, they should be used in addition to the advice provided by the physicians.

Indexed as

age-related macular degenerationChatGPT4large language modelqualitative evaluationquestion

Identifiers

PMID39061606
PMCPMC11275354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.